Sadao Suzuki

Prof. Sadao Suzuki

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Papillomavirus Research
Verified
Journal Article
Open access
SSSadao Suzuki
Sadao Suzuki
AHAkihiro Hosono
Akihiro Hosono
Nagoya City introduced free HPV vaccination in 2010 and in April 2013 the Ministry of Health, Labour and Welfare included the HPV vaccine in the National Immunization Program. However, in June 2013, the Ministry suspended proactive recommendation of the vaccine after unconfirmed reports of adverse events. To investigate any potential association between the vaccine and reported symptoms, Nagoya City conducted a questionnaire-based survey. Participants were 71,177 female residents of Nagoya City born between April 2, 1994 and April 1, 2001. The anonymous postal questionnaire investigated the onset of 24 symptoms (primary outcome), associated hospital visits, frequency, and influence on school attendance. Totally, 29,846 residents responded. No significant increase in occurrence of any of the 24 reported post-HPV vaccination symptoms was found. The vaccine was associated with increased age-adjusted odds of hospital visits for "abnormal amount of menstrual bleeding" (OR: 1.43, 95% CI: 1.13-1.82), "irregular menstruation" (OR: 1.29, 95% CI: 1.12-1.49), "severe headaches" (OR: 1.19, 95% CI: 1.02-1.39), and chronic, persisting "abnormal amount of menstrual bleeding" (OR 1.41, 95% CI: 1.11-1.79). No symptoms significantly influenced school attendance and no accumulation of symptoms was observed. The results suggest no causal association between the HPV vaccines and reported symptoms.

5 December 2021 in Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
KTKenji Takeuchi
Kenji Takeuchi
MNMariko Naito
Mariko Naito
SKSayo Kawai
Sayo Kawai
MTMineko Tsukamoto
Mineko Tsukamoto
YKYuka Kadomatsu
Yuka Kadomatsu
KWKenji Wakai
Kenji Wakai
Background: The Japan Multi-institutional Collaborative Cohort (J-MICC) study was launched in 2005 to examine gene–environment interactions in lifestyle-related diseases, including cancers, among the Japanese. This report describes the study design and baseline profile of the study participants.Methods: The participants of the J-MICC Study were individuals aged 35 to 69 years enrolled from respondents to study announcements in specified regions, inhabitants attending health checkup examinations provided by local governments, visitors at health checkup centers, and first-visit patients at a cancer hospital in Japan. At the time of the baseline survey, from 2005 to 2014, we obtained comprehensive information regarding demographics, education, alcohol consumption, smoking, sleeping, exercise, food intake frequency, medication and supplement use, personal and family disease history, psychological stress, and female reproductive history, and collected peripheral blood samples.Results: The baseline survey included 92,610 adults (mean age: 55.2 [9.4] years, 44.1% men) from 14 study regions in 12 prefectures. The participation rate was 33.5%, with participation ranging from 19.7% to 69.8% in different study regions. The largest number of participants was in the age groups of 65–69 years for men and 60–64 years for women. There were differences in body mass index, educational attainment, alcohol consumption, smoking, and sleep duration between men and women.Conclusions: The J-MICC Study collected lifestyle and clinical data and biospecimens from over 90,000 participants. This cohort is expected to be a valuable resource for the national and international scientific community in providing evidence to support longer healthy lives.

1 May 2004 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
SSSadao Suzuki
Sadao Suzuki
TMTakeo Moro-Oka
Takeo Moro-Oka
NCNiteesh K. Choudhry
Niteesh K. Choudhry

18 May 2016 in European Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
TIT Isomura
T Isomura
SSSadao Suzuki
Sadao Suzuki
HOH Origasa
H Origasa
AHA Hosono
A Hosono
MSM Suzuki
M Suzuki
TKT Koga
T Koga
There remain liver-related safety concerns, regarding potential hepatotoxicity in humans, induced by green tea intake, despite being supposedly beneficial. Although many randomized controlled trials (RCTs) of green tea extracts have been reported in the literature, the systematic reviews published to date were only based on subjective assessment of case reports. To more objectively examine the liver-related safety of green tea intake, we conducted a systematic review of published RCTs. A systematic literature search was conducted using three databases (PubMed, EMBASE and Cochrane Central Register of Controlled Trials) in December 2013 to identify RCTs of green tea extracts. Data on liver-related adverse events, including laboratory test abnormalities, were abstracted from the identified articles. Methodological quality of RCTs was assessed. After excluding duplicates, 561 titles and abstracts and 119 full-text articles were screened, and finally 34 trials were identified. Of these, liver-related adverse events were reported in four trials; these adverse events involved seven subjects (eight events) in the green tea intervention group and one subject (one event) in the control group. The summary odds ratio, estimated using a meta-analysis method for sparse event data, for intervention compared with placebo was 2.1 (95% confidence interval: 0.5–9.8). The few events reported in both groups were elevations of liver enzymes. Most were mild, and no serious liver-related adverse events were reported. Results of this review, although not conclusive, suggest that liver-related adverse events after intake of green tea extracts are expected to be rare.

1 January 2013 in Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
SSSadao Suzuki
Sadao Suzuki
MKMasayo Kojima
Masayo Kojima
STShinkan Tokudome
Shinkan Tokudome
MMMitsuru Mori
Mitsuru Mori
FSFumio Sakauchi
Fumio Sakauchi
ATAkiko Tamakoshi
Akiko Tamakoshi
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

25 October 2021 in Preventive Medicine Reports
Verified
Journal Article
Open access
SKSakurako Katsuura-Kamano
Sakurako Katsuura-Kamano
KAKokichi Arisawa
Kokichi Arisawa
HUHirokazu Uemura
Hirokazu Uemura
VNVan Tien Nguyen
Van Tien Nguyen
TTToshiro Takezaki
Toshiro Takezaki
KWKenji Wakai
Kenji Wakai
• Skipping breakfast was associated with metabolic syndrome in men. • Short sleep duration was also associated with metabolic syndrome in men. • There was no association with metabolic syndrome in women. • The interaction of the two factors on metabolic syndrome was not significant.